Literature DB >> 2874504

The significance of beta-adrenoceptor down regulation in the desipramine action in the forced swimming test.

Y Kitada, T Miyauchi, T Kosasa, S Satoh.   

Abstract

The present studies were undertaken to clarify whether central beta-adrenoceptor down regulation is responsible for the greater effect of chronic treatment with desipramine (DMI) compared with acute treatment in the forced swimming test in rats. Repetitive administration of DMI activated the rat behaviour pattern and consequently reduced the duration of immobility. The degree of activation depended on the length of treatment, i.e. no effect when given in a single dose, moderate effect when given subchronically (3 doses) and marked activation after chronic (31 doses) treatment. Chronic treatment with DMI also produced a decrease in 3H-dihydroalprenolol (3H-DHA) binding site in the cerebral cortex. Acute stimulation of brain beta-adrenoceptors by intracerebroventricular (i.c.v.) isoprenaline significantly, though partially, attenuated the behavioural effect of chronic DMI by beta 1-adrenoceptor-related mechanisms. Similarly, chronic i.c.v. co-administration of atenolol or practolol, beta 1-adrenoceptor antagonists, together with DMI attenuated both beta-adrenoceptor down regulation and the behavioural activation by chronic DMI. On the other hand, chronic i.c.v. administration of isoprenaline, supposedly leading to down regulation of beta-adrenoceptors, facilitated the activating behavioural effect of DMI, as a single dose became effective. Changes, however, in 3H-DHA binding parameters in the cerebral cortex were not observed after chronic isoprenaline. These results suggest that down regulation of beta-adrenoceptors in brain is responsible, at least in part, for the marked activatory effect of chronic DMI in the forced swimming test, possibly by reducing an inhibitory function of beta 1-adrenoceptor mediated mechanisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874504     DOI: 10.1007/bf00569656

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain.

Authors:  D A Bergstrom; K J Kellar
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

2.  Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain.

Authors:  J Vetulani; F Sulser
Journal:  Nature       Date:  1975-10-09       Impact factor: 49.962

3.  Development of beta-adrenergic receptor subsensitivity by antidepressants.

Authors:  S P Banerjee; L S Kung; S J Riggi; S K Chanda
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

4.  Behavioural despair in rats: a new model sensitive to antidepressant treatments.

Authors:  R D Porsolt; G Anton; N Blavet; M Jalfre
Journal:  Eur J Pharmacol       Date:  1978-02-15       Impact factor: 4.432

Review 5.  On the slowness of action of tricyclic antidepressant drugs.

Authors:  I Oswald; V Brezinova; D L Dunleavy
Journal:  Br J Psychiatry       Date:  1972-06       Impact factor: 9.319

6.  Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.

Authors:  S J Peroutka; S H Snyder
Journal:  Science       Date:  1980-10-03       Impact factor: 47.728

7.  Brain adrenergic receptors and resistance to stress.

Authors:  E A Stone; J E Platt
Journal:  Brain Res       Date:  1982-04-15       Impact factor: 3.252

8.  Modulation of rat brain alpha 2- and beta-adrenergic receptor sensitivity following long-term treatment with antidepressants.

Authors:  M Asakura; T Tsukamoto; K Hasegawa
Journal:  Brain Res       Date:  1982-03-04       Impact factor: 3.252

9.  Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment.

Authors:  D A Bergstrom; K J Kellar
Journal:  J Pharmacol Exp Ther       Date:  1979-05       Impact factor: 4.030

10.  Effects of antidepressants in the rat forced swimming test.

Authors:  Y Kitada; T Miyauchi; A Satoh; S Satoh
Journal:  Eur J Pharmacol       Date:  1981-06-19       Impact factor: 4.432

View more
  6 in total

1.  Effects of a single or repeated administration of the benzodiazepine inverse agonist FG7142 on behaviour and cortical adrenoceptor binding in the rat.

Authors:  S C Stanford; H A Baldwin; S E File
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  Is the forced swimming test a suitable model for revealing antidepressant activity?

Authors:  F Borsini; A Meli
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Lack of relationship between effect of desipramine on forced swimming test and brain levels of desipramine or its demethylated metabolite in rats.

Authors:  A Mancinelli; V D'Aranno; F Borsini; A Meli
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.

Authors:  Zaorui Zhao; Alicia M Baros; Han-Ting Zhang; M Danet S Lapiz; Corina O Bondi; David A Morilak; James M O'Donnell
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

5.  Independent regulation of beta 1- and beta 2-adrenoceptors.

Authors:  M Beer; S Hacker; J Poat; S M Stahl
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

Review 6.  Molecular mechanism of noradrenaline during the stress-induced major depressive disorder.

Authors:  Kenjiro Seki; Satomi Yoshida; Manoj Kumar Jaiswal
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.